New study tests if albumin changes can forecast sepsis survival better than current methods.

NCT ID NCT07289906

Ongoing Diagnosis Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two blood tests—mass change in serum albumin and serum lactic acid—to see which better predicts whether non-surgical ICU patients with sepsis will be discharged or die. Researchers will track 40 adults aged 18-70 with sepsis, excluding those with liver disease or certain kidney conditions. The goal is to find a more reliable way to forecast sepsis prognosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a more accurate tool to predict whether sepsis patients will recover or worsen, helping guide treatment decisions.
What could go wrong: This is a small, early-stage study with only 40 participants, so results may not apply to all patients. The test is not a treatment and will not directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROGNOSIS PREDICTION OF SEPSIS IN ICU PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROGNOSIS PREDICTION OF SEPSIS IN ICU PATIENTS

Contacts and locations

Locations

Hospitals ofAin shams university

Cairo, Elabasya, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.